Author: Morokutti-Kurz, Martina; Graf, Christine; Prieschl-Grassauer, Eva
Title: Amylmetacresol/2,4-dichlorobenzyl alcohol, hexylresorcinol, or carrageenan lozenges as active treatments for sore throat Document date: 2017_2_28
ID: q5j3vcfm_42
Snippet: for lozenges containing AMC/DCBA at a low pH. Currently a series of such lozenges with the same active ingredients but different flavors is available; additionally, lozenges were marketed, containing HR, as active agent. Shephard and Zybeshari 6 tested the virucidal effect of AMC/DCBA and HR either as free substances or processed into lozenges. The experimental setup was the same in both publications. Lozenges were diluted in 5 or 4.5 mL artifici.....
Document: for lozenges containing AMC/DCBA at a low pH. Currently a series of such lozenges with the same active ingredients but different flavors is available; additionally, lozenges were marketed, containing HR, as active agent. Shephard and Zybeshari 6 tested the virucidal effect of AMC/DCBA and HR either as free substances or processed into lozenges. The experimental setup was the same in both publications. Lozenges were diluted in 5 or 4.5 mL artificial saliva or medium. Nine parts of the lozenges solution were then directly mixed with one part of the respective virus stock at a known titer. After different contact times, the residual infective virus was determined using quantitative titration. Oxford et al 5 also checked for morphological changes using electron microscopy and found clumping of viruses and denaturation of spike proteins within 2 minutes of contact time. From these results it is concluded that lozenges containing either AMC/DCBA or HR might exhibit a local antiviral effect in patients with sore throat due to viral RTIs. However, the experimental setup does not allow the extrapolation of these data to a potential clinical effect. Dissolution of the lozenge in the mouth stimulates saliva production, resulting in a flow rate of 1.5-6 mL saliva/minute. 14 As a consequence, 20-80 mL saliva were produced during the whole dissolution process of 13 minutes and 20 seconds. Therefore, the concentration of matrix and active ingredients at which the effect of the AMC/DCBA or HR containing lozenges was
Search related documents:
Co phrase search for related documents- active ingredient and virus stock: 1, 2
- antiviral effect and virucidal effect: 1, 2, 3, 4, 5, 6, 7, 8
- clinical effect and viral rti: 1
- contact time and virucidal effect: 1, 2, 3
- contact time and virus stock: 1, 2, 3
- dissolution process and virucidal effect: 1
- electron microscopy and virucidal effect: 1, 2, 3
- electron microscopy and virus stock: 1, 2, 3, 4
- hr AMC DCBA effect and virucidal effect: 1, 2
- hr AMC DCBA virucidal effect and virucidal effect: 1
- infective virus and virus stock: 1, 2
- mouth lozenge and virucidal effect: 1
- production saliva and virucidal effect: 1
- sore throat and virucidal effect: 1, 2
- spike protein and virus stock: 1
Co phrase search for related documents, hyperlinks ordered by date